S

SCI Pharmtech Inc
TWSE:4119

Watchlist Manager
SCI Pharmtech Inc
TWSE:4119
Watchlist
Price: 90 TWD 0.11% Market Closed
Market Cap: 10.8B TWD
Have any thoughts about
SCI Pharmtech Inc?
Write Note

Intrinsic Value

The intrinsic value of one SCI Pharmtech Inc stock under the Base Case scenario is 56.35 TWD. Compared to the current market price of 90 TWD, SCI Pharmtech Inc is Overvalued by 37%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
56.35 TWD
Overvaluation 37%
Intrinsic Value
Price
S
Worst Case
Base Case
Best Case

Valuation History
SCI Pharmtech Inc

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
SCI Pharmtech Inc
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for SCI Pharmtech Inc cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
How do you feel about SCI Pharmtech Inc?
Bearish
Neutral
Bullish

Fundamental Analysis

90 TWD
+0.11%
+0.11%
Benchmark
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

SCI Pharmtech Inc
TW
Pharmaceuticals
Market Cap
10.8B TWD
IPO
Aug 12, 2002
Employees
-
Taiwan
Market Cap
10.8B TWD
Industry
Pharmaceuticals
IPO
Aug 12, 2002
Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about SCI Pharmtech Inc

Provide an overview of the primary business activities
of SCI Pharmtech Inc.

What unique competitive advantages
does SCI Pharmtech Inc hold over its rivals?

What risks and challenges
does SCI Pharmtech Inc face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for SCI Pharmtech Inc.

Provide P/S
for SCI Pharmtech Inc.

Provide P/E
for SCI Pharmtech Inc.

Provide P/OCF
for SCI Pharmtech Inc.

Provide P/FCFE
for SCI Pharmtech Inc.

Provide P/B
for SCI Pharmtech Inc.

Provide EV/S
for SCI Pharmtech Inc.

Provide EV/GP
for SCI Pharmtech Inc.

Provide EV/EBITDA
for SCI Pharmtech Inc.

Provide EV/EBIT
for SCI Pharmtech Inc.

Provide EV/OCF
for SCI Pharmtech Inc.

Provide EV/FCFF
for SCI Pharmtech Inc.

Provide EV/IC
for SCI Pharmtech Inc.

Show me price targets
for SCI Pharmtech Inc made by professional analysts.

What are the Revenue projections
for SCI Pharmtech Inc?

How accurate were the past Revenue estimates
for SCI Pharmtech Inc?

What are the Net Income projections
for SCI Pharmtech Inc?

How accurate were the past Net Income estimates
for SCI Pharmtech Inc?

What are the EPS projections
for SCI Pharmtech Inc?

How accurate were the past EPS estimates
for SCI Pharmtech Inc?

What are the EBIT projections
for SCI Pharmtech Inc?

How accurate were the past EBIT estimates
for SCI Pharmtech Inc?

Compare the revenue forecasts
for SCI Pharmtech Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of SCI Pharmtech Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of SCI Pharmtech Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of SCI Pharmtech Inc compared to its peers.

Compare the P/E ratios
of SCI Pharmtech Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing SCI Pharmtech Inc with its peers.

Analyze the financial leverage
of SCI Pharmtech Inc compared to its main competitors.

Show all profitability ratios
for SCI Pharmtech Inc.

Provide ROE
for SCI Pharmtech Inc.

Provide ROA
for SCI Pharmtech Inc.

Provide ROIC
for SCI Pharmtech Inc.

Provide ROCE
for SCI Pharmtech Inc.

Provide Gross Margin
for SCI Pharmtech Inc.

Provide Operating Margin
for SCI Pharmtech Inc.

Provide Net Margin
for SCI Pharmtech Inc.

Provide FCF Margin
for SCI Pharmtech Inc.

Show all solvency ratios
for SCI Pharmtech Inc.

Provide D/E Ratio
for SCI Pharmtech Inc.

Provide D/A Ratio
for SCI Pharmtech Inc.

Provide Interest Coverage Ratio
for SCI Pharmtech Inc.

Provide Altman Z-Score Ratio
for SCI Pharmtech Inc.

Provide Quick Ratio
for SCI Pharmtech Inc.

Provide Current Ratio
for SCI Pharmtech Inc.

Provide Cash Ratio
for SCI Pharmtech Inc.

What is the historical Revenue growth
over the last 5 years for SCI Pharmtech Inc?

What is the historical Net Income growth
over the last 5 years for SCI Pharmtech Inc?

What is the current Free Cash Flow
of SCI Pharmtech Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for SCI Pharmtech Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
SCI Pharmtech Inc

Current Assets 2.1B
Cash & Short-Term Investments 543.5m
Receivables 869.5m
Other Current Assets 723.3m
Non-Current Assets 5.1B
Long-Term Investments 473.2m
PP&E 4.3B
Intangibles 39.8m
Other Non-Current Assets 302.6m
Current Liabilities 907.4m
Accounts Payable 63.1m
Short-Term Debt 101m
Other Current Liabilities 743.3m
Non-Current Liabilities 901m
Long-Term Debt 767.8m
Other Non-Current Liabilities 133.2m
Efficiency

Earnings Waterfall
SCI Pharmtech Inc

Revenue
1.4B TWD
Cost of Revenue
-1B TWD
Gross Profit
383.2m TWD
Operating Expenses
-223.3m TWD
Operating Income
159.9m TWD
Other Expenses
324.3m TWD
Net Income
484.2m TWD

Free Cash Flow Analysis
SCI Pharmtech Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

Profitability Score
Profitability Due Diligence

SCI Pharmtech Inc's profitability score is 47/100. The higher the profitability score, the more profitable the company is.

ROE is Increasing
Positive Gross Profit
Positive Net Income
Exceptional 1-Year Revenue Growth
47/100
Profitability
Score

SCI Pharmtech Inc's profitability score is 47/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

SCI Pharmtech Inc's solvency score is 85/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Long-Term Solvency
Low D/E
85/100
Solvency
Score

SCI Pharmtech Inc's solvency score is 85/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
SCI Pharmtech Inc

There are no price targets for SCI Pharmtech Inc.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for SCI Pharmtech Inc?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for SCI Pharmtech Inc is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

See Also

Discover More
What is the Intrinsic Value of one SCI Pharmtech Inc stock?

The intrinsic value of one SCI Pharmtech Inc stock under the Base Case scenario is 56.35 TWD.

Is SCI Pharmtech Inc stock undervalued or overvalued?

Compared to the current market price of 90 TWD, SCI Pharmtech Inc is Overvalued by 37%.

Back to Top